Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Preoperative and postoperative IL-2 immunotherapy in pancreatic cancer surgery
2004-002033-39Phase 2Completed
- Sponsor
- Fondazione IRCCS San Gerardo dei Tintori
- Start
- Aug 2004
- Modality
- Cytokines & Interferons → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised trial of aldesleukin in pancreatic cancer (PC) (2 arms), sponsored by Fondazione IRCCS San Gerardo dei Tintori. Started Aug 2004; status: completed.
02
Drugs
aldesleukin
03
Conditions
pancreatic cancer (PC)
Beyond the preview
Go deeper on 2004-002033-39.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-002033-39.